In contrast, B-ALL patients with favorable cytogenetics (TEL-AML1 [ETV6-RUNX1] fusion) were enriched in immune cluster 2 (P = 0.03; Figure 7C). The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.